Immatics N.V.
IMTX • NASDAQ
Immatics N.V. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Harpreet Singh, with a market cap of $1.3B.
CEOHarpreet Singh
Next Earnings
Upcoming earnings announcement for Immatics N.V.
Date
Tuesday, May 12, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.42
Revenue Estimate
$14.6M
Earnings History
Past 12 earnings reports for Immatics N.V.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 5, 2026 | Q4 2025 | -$0.34Est: -$0.48 | +29.2% | $23.0MEst: $12.2M | +88.9% | — |
| Nov 17, 2025 | Q3 2025 | -$0.49Est: -$0.50 | +2.0% | $6.1MEst: $12.3M | -50.7% | — |
| Aug 13, 2025 | Q2 2025 | -$0.66Est: -$0.38 | -73.7% | $5.5MEst: $14.3M | -61.5% | — |
| May 13, 2025 | Q1 2025 | -$0.35Est: -$0.33 | -6.1% | $19.5MEst: $15.4M | +26.7% | — |
| Mar 27, 2025 | Q4 2024 | $0.48 | — | $60.0M | — | — |
| Nov 18, 2024 | Q3 2024 | -$0.12Est: -$0.29 | +58.6% | $55.6MEst: $17.0M | +227.8% | — |
| Aug 13, 2024 | Q2 2024 | -$0.18Est: -$0.31 | +41.9% | $20.2MEst: $14.9M | +35.8% | — |
| May 14, 2024 | Q1 2024 | -$0.04Est: -$0.22 | +80.5% | $32.9MEst: $21.9M | +50.3% | — |
| Mar 21, 2024 | Q4 2023 | -$0.32Est: -$0.35 | +8.6% | $17.1MEst: $16.4M | +4.7% | — |
| Nov 14, 2023 | Q3 2023 | -$0.35Est: -$0.43 | +18.6% | $6.5MEst: $11.1M | -41.6% | — |
| Aug 17, 2023 | Q2 2023 | -$0.35Est: -$0.24 | -45.4% | $24.4MEst: $18.9M | +28.7% | — |
| May 16, 2023 | Q1 2023 | -$0.28Est: -$0.30 | +6.7% | $10.5MEst: $13.0M | -18.9% | — |